Sergio Castillo Fernandez

Title: The Innovations of Sergio Castillo Fernandez

Introduction

Sergio Castillo Fernandez is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of cardiovascular and thromboembolic disease research. With a total of 4 patents, his work focuses on improving risk assessment methods for these critical health issues.

Latest Patents

One of his latest patents addresses cardiovascular disease. This invention relates to a method for the reclassification of a subject to a more appropriate risk assessment than that obtained using traditional algorithms such as Framingham, Regicor, Score, Procamor, and Qrisk. It combines the presence of various polymorphisms with conventional risk factors to determine the risk of suffering from cardiovascular disease. Additionally, he has developed a method for assessing thromboembolic event risk based on genetic variants. This invention also combines polymorphic markers with conventional risk factors to evaluate the risk of thromboembolism.

Career Highlights

Sergio has worked with several companies, including Gendiag and Progenika Biopharma. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in medical technology.

Collaborations

Throughout his career, Sergio has collaborated with esteemed colleagues such as Roberto Elosua Llanos and Jaume Marrugat De La Iglesia. These partnerships have further enriched his research and development efforts.

Conclusion

Sergio Castillo Fernandez is a prominent figure in the field of medical innovation, particularly in cardiovascular and thromboembolic disease research. His patents reflect a commitment to enhancing risk assessment methods, ultimately aiming to improve patient outcomes.